View Cart  

Par Acquires Seroquel ANDA From Handa, Expects First-Filer Exclusivity Upon 2016 Launch

A A
Par Pharmaceutical can launch a generic version of AstraZeneca’s extend-release antipsychotic Seroquel XR by November 2016 following its acquisition of Handa Pharmaceuticals’ ANDA.

To View This Article:

Login

Subscribe To Drug Industry Daily